TG Therapeutics Recaps Schedule of Triple Therapy Data Presentations at the Upcoming 61st American Society of Hematology Annual Meeting and Exposition
December 06, 2019 07:30 ET
|
TG Therapeutics, Inc.
NEW YORK, Dec. 06, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today recapped the schedule of triple therapy data presentations, at the upcoming 61st American Society of...
Inceptua Medicines Access and Onconova Therapeutics Announce Pre-approval Access Collaboration for Rigosertib in Selected Countries Outside the US
December 06, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa. and LUXEMBOURG, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a Phase 3-stage biopharmaceutical company discovering and developing novel...
Lumina Gold Announces Increase to Previously Announced Private Placement
December 06, 2019 07:30 ET
|
Lumina Gold Corp.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Lumina Gold Corp. (TSXV: LUM) (OTCQX:...
Todos To Present At Upcoming 12th Annual LD Micro Main Event
December 06, 2019 07:29 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Summit Announces a Proposed Subscription and Placing to Raise approximately $50.0 Million and Notice of General Meeting
December 06, 2019 07:24 ET
|
Summit Therapeutics plc
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, OR INTO ANY JURISDICTION IN...
Announcement of managers’ transactions: CFO Peter Klovgaard-Jørgensen has purchased shares in H+H International A/S
December 06, 2019 07:23 ET
|
H+H International A/S
Company announcement No. 382 H+H International A/S has received notification pursuant to article 19 of EU Regulation no. 596/2014 of the below transaction(s) related to shares or...
Iliad : Informations relatives au nombre total de droits de vote et d'actions composant le capital au 30 novembre 2019
December 06, 2019 07:17 ET
|
Iliad
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de Commerce et l’article 223-16 du règlement général de l’Autorité des marchés...
Sista dag för handel med BTA B i Oboya
December 06, 2019 07:14 ET
|
Oboya Horticulture Industries AB
Oboya Horticulture Industries AB: s (” Oboya” eller” Bolaget”) företrädesemission har registrerats vid Bolagsverket. Sista dag för handel i Bolagets betalda tecknade aktier, OBOYA BTA B, är den 11...
Ny CEO i ChemoMetec tiltræder den 2. januar 2020
December 06, 2019 07:07 ET
|
Chemometec A/S
MEDDELELSE NR. 181 Der er indgået aftale om, at ChemoMetecs nye CEO Steen Søndergaard tiltræder den 2. januar 2020. I en tidligere meddelelse, offentliggjort den 1. december 2019, blev det meddelt,...
Data from Investigator-Sponsored Phase 2 Study of Calithera’s Telaglenastat with Azacitidine in Myelodysplastic Syndrome to be Presented at ASH Annual Meeting 2019
December 06, 2019 07:05 ET
|
Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 06, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small...
- September 27, 2024 00:00 ET Redefining the “Health or Wealth” Dilemma through HealthFi with Dynachain
- September 26, 2024 23:54 ET The Open Art by Blum, TONX, and TON Society Draws 11,280+ Registered Attendees, Becoming the Largest Event of Token2049 Week